Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study. 36600297 Papadimitriou N , Bull CJ , Jenab M , Hughes DJ , Bell JA , Sanderson E , Timpson NJ , Smith GD , Albanes D , Campbell PT , Küry S , Le Marchand L , Ulrich CM , Visvanathan K , Figueiredo JC , Newcomb PA , Pai RK , Peters U , Tsilidis KK , Boer JMA … BMC Med 2023 PLCO
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. 36539618 Fernandez-Rozadilla C , Timofeeva M , Chen Z , Law P , Thomas M , Schmit S , Díez-Obrero V , Hsu L , Fernandez-Tajes J , Palles C , Sherwood K , Briggs S , Svinti V , Donnelly K , Farrington S , Blackmur J , Vaughan-Shaw P , Shu XO , Long J , Cai Q … Nat Genet 2023 PLCO
Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis. 36512731 Lu Y , Zhao YC , Chang-Claude J , Gruber SB , Gsur A , Offit K , Vodickova L , Woods MO , Nguyen LH , Wade KH , Carreras-Torres R , Moreno V , Buchanan DD , Cotterchio M , Chan AT , Phipps AI , Peters U , Song M Cancer Epidemiol Biomarkers Prev 2023 PLCO
Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 36843273 Chang VC, Rhee J, Berndt SI, Moore SC, Freedman ND, Jones RR, Silverman DT, Gierach GL, Hofmann JN, Purdue MP Int J Cancer 2023 PLCO
A Metabolomic Signature of Obesity and Risk of Colorectal Cancer: Two Nested Case-Control Studies. 36837854 Yang M, Zhu C, Du L, Huang J, Lu J, Yang J, Tong Y, Zhu M, Song C, Shen C, Dai J, Lu X, Xu Z, Li N, Ma H, Hu Z, Gu D, Jin G, Hang D, Shen H Metabolites 2023 PLCO
Body mass index and molecular subtypes of colorectal cancer. 36445035 Murphy N , Newton CC , Song M , Papadimitriou N , Hoffmeister M , Phipps AI , Harrison TA , Newcomb PA , Aglago EK , Berndt SI , Brenner H , Buchanan DD , Cao Y , Chan AT , Chen X , Cheng I , Chang-Claude J , Dimou N , Drew D , Farris AB , French AJ… J Natl Cancer Inst 2023 PLCO
A prospective nested case-control study of serum concentrations of per- and polyfluoroalkyl substances and aggressive prostate cancer risk. 36958379 Rhee J, Barry KH, Huang WY, Sampson JN, Hofmann JN, Silverman DT, Calafat AM, Botelho JC, Kato K, Purdue MP, Berndt SI Environ Res 2023 PLCO
Explainable discovery of disease biomarkers: The case of ovarian cancer to illustrate the best practice in machine learning and Shapley analysis. 37062419 Huang W, Suominen H, Liu T, Rice G, Salomon C, Barnard AS J Biomed Inform 2023 PLCO
Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study. 37255940 Zhu Z, Peng L, Gu H, Tang Y, Xiao Y, He H, Yang M, Xiang L, Wang Y Front Nutr 2023 PLCO
Multi-Label Local to Global Learning: A Novel Learning Paradigm for Chest X-ray Abnormality Classification. 37252867 Liu Z, Cheng Y, Tamura S IEEE J Biomed Health Inform 2023 PLCO
Liver cancer risk quantification through an artificial neural network based on personal health data. 37211681 Ataei A, Deng J, Muhammad W Acta Oncol 2023 PLCO
Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. 37210288 Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, Joseph V, Florez-Vargas O, Dyrskjøt L, Figueroa J, Dutta D, Giles GG, Hildebrandt MAT, Offit K, Kogevinas M, Weiderpass E, McCullough ML, Freedman ND, Albanes D, Kooperber… Eur Urol 2023 PLCO
Lipidomics and pancreatic cancer risk in two prospective studies. 37169992 Naudin S, Sampson JN, Moore SC, Albanes D, Freedman ND, Weinstein SJ, Stolzenberg-Solomon R Eur J Epidemiol 2023 PLCO
Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer. 37163267 Loomans-Kropp HA, Umar A JAMA Netw Open 2023 PLCO
Quantifying the Contributions of Environmental Factors to Prostate Cancer and Detecting Risk-Related Diet Metrics and Racial Disparities. 37139178 Zhang W, Zhang K Cancer Inform 2023 PLCO
A nested case-control study of untargeted albumin adductomics and acute myeloid leukemia. 37138425 Rahman ML, Bassig BA, Grigoryan H, Hu W, Hosgood HD, Huang WY, Wong JYY, Strickland P, Rappaport SM, Lan Q, Rothman N Int J Cancer 2023 PLCO
Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial. 37384841 Yim K, Ma C, Carlsson S, Lilja H, Mucci L, Penney K, Kibel AS, Eggener S, Preston MA J Urol 2023 PLCO
Obesity and prostate cancer screening, incidence, and mortality in the PLCO Cancer Screening Trial. 37382561 Hurwitz LM, Dogbe N, Hughes Barry K, Koutros S, Berndt SI J Natl Cancer Inst 2023 PLCO
Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. 37379494 Irajizad E, Fahrmann JF, Marsh T, Vykoukal J, Dennison JB, Long JP, Do KA, Feng Z, Hanash S, Ostrin EJ J Clin Oncol 2023 PLCO
Dietary glycemic index, glycemic load, and renal cancer risk: findings from prostate, lung, colorectal, and ovarian cancer trial. 37346909 Qi H, Xia D, Xu X Front Nutr 2023 PLCO